Manfred Ballmann

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutation

John P. Clancy, Steven M. Rowe, Frank J. Accurso et al. · Thorax · 2011 · 496 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

European best practice guidelines for cystic fibrosis neonatal screening

Carlo Castellani, Kevin W Southern, K. Brownlee et al. · Journal of Cystic Fibrosis · 2009 · 243 citations · Full text

Medicine, Child Health, Pediatrics +14

Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis

K. Paul, Ernst Rietschel, Manfred Ballmann et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 166 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Alteration of the Pulmonary Surfactant System in Full-Term Infants with Hereditary ABCA3 Deficiency

Frank Brasch, Sven Schimanski, Christian Mühlfeld et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 150 citations

Life Sciences, Genetics, Molecular Biology +17

Quality of life is associated with physical activity and fitness in cystic fibrosis

Helge Hebestreit, Kerstin Schmid, Stephanie Kieser et al. · BMC Pulmonary Medicine · 2014 · 149 citations · Full text

Education, Rehabilitation Medicine, Health-related Fitness +16